These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6108573)

  • 1. Increase of plasma ACTH in the rat following the administration of D-met2-pro5-enkephalinamide.
    Reina RA; Costa G; Scoto GM; Spadaro C; Spampinato S; Ferri S
    Pharmacol Res Commun; 1980 May; 12(5):479-82. PubMed ID: 6108573
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
    Rónai AZ; Berzétei IP; Bajusz S; Székely JI
    J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
    [No Abstract]   [Full Text] [Related]  

  • 4. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
    Köves K; Marton J; Molnár J; Halász B
    Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
    Székely JI; Miglécz E; Rónai AZ
    Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.
    Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE
    Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
    Wollemann M; Szebeni A; Bajusz S; Gráf L
    Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
    Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
    Miglécz E; Székely JI; Dunai-Kovács Z
    Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
    Vermes I; Szontágh L; Telegdy G
    Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.
    Phillips AG; LePiane FG
    Behav Brain Res; 1982 Jun; 5(2):225-9. PubMed ID: 7104089
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of D-Ala2-met-enkephalinamide and morphine on the activity of choline acetyltransferase and acetylcholinesterase in rat brain.
    Herman ZS; Kowalski J
    Acta Physiol Pol; 1981; 32(3):233-7. PubMed ID: 7304195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoaminergic modulation of the analgesia induced in rats by (D-Ala2)-met-enkephalinamide (DADA)].
    Garzón J; Moratalla R; del Río J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):177-9. PubMed ID: 546335
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation of pulmonary J receptors by an enkephalin-analog.
    Sapru HN; Willette RN; Krieger AJ
    J Pharmacol Exp Ther; 1981 Apr; 217(1):228-34. PubMed ID: 7205657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neuropharmacology of D-Ala2-Met-enkephalinamide and its interactions with taurine in rats.
    Izumi K; Munekata E; Yamamoto H; Yoshida M; Nakanishi T; Wong P; Barbeau A
    Adv Exp Med Biol; 1981; 139():325-43. PubMed ID: 7199249
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of (D-alanine2, methionine5) enkephalinamide on the release of acetylcholine and noradrenaline from brain slices and isolated nerve terminals.
    Jones CA; Marchbanks RM
    Biochem Pharmacol; 1982 Feb; 31(3):455-8. PubMed ID: 7073771
    [No Abstract]   [Full Text] [Related]  

  • 17. Central peptidergic stimulation in blood pressure control: role of enkephalins in rats.
    Yukimura T; Unger T; Rascher W; Lang RE; Ganten D
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():347s-350s. PubMed ID: 7318336
    [No Abstract]   [Full Text] [Related]  

  • 18. Noradrenergic terminal excitability: effects of opioids.
    Nakamura S; Tepper JM; Young SJ; Ling N; Groves PM
    Neurosci Lett; 1982 May; 30(1):57-62. PubMed ID: 6124916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the respiratory activity of (D-Ala2)methionine-enkephalinamide.
    Zobrist RH; Allerton HW; Isom GE
    Eur J Pharmacol; 1981 Mar; 70(2):121-8. PubMed ID: 6790294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of four 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys.
    Hartvig P; Någren K; Lundberg PO; Muhr C; Terenius L; Lundqvist H; Lärkfors L; Långström B
    Regul Pept; 1986 Dec; 16(1):1-13. PubMed ID: 3492729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.